AbramsJ. S.: Blood pressure response to the portal infusion of angiotensin II, Surg. Forum, 17; 133–134 (1966.
2.
AoyagiT., LowensteinL. M.: The effect of bile acids and renal ischemia on renal function. J. Lab. Clin., Med., 71; 686 (1968).
3.
ArmstrongM. D., ShawK. N. F., WallP. E: J. Biol. Chem., 218; 293 (1956).
4.
AyersC. R.: Plasma renin activity and renin-substrate concentration in patients with liver disease. Circ. Res., 20; 594 (1967).
5.
BakerS. B.: The blood supply of the renal papille. Brit J. Urol., 31; 53–59 (1959).
6.
BaldusW. P., FeichterR. N., SummerskillW. H.: The kidney in cirrhosis II: Disorders of renal function. Ann. Intern. Med., 60; 366–377 (1964).
7.
BaldusW. P.: Etiology and ménagement of renal failure in cirrhosis and portal hypertension. Ann. N.Y. Acad. Sci., 170; 267–278 (1969).
8.
BaldusW. P., SummerskillW. H. J., HuntJ. C.: Renal circulation in cirrhosis observation based on catherizantion of the renal vein. J. Clin. Invest., 43; 1090–1097 (1964).
9.
BargerA. C.: Renal hemodynamic factors in congestive heart failure. Ann. N. Y. Acad. Sci., 139; 276 (1966).
10.
BarnardoD. E., StrongC. G., BaldusW. P.: Elevated hepatic venous renin activity in cirrhosis: evidence for impaired hepatic inactivation and portal venous origin (abstract). Ann., Intern. Med., 70; 1065 (1969).
11.
BarnardoD. E., BaldusW. P., MaherF. T.: Effects of dopamine on renal function in patients with cirrhosis. Gastroenterology, 58; 524–531 (1970).
12.
BarrR. W., SommersS. C.: Endocrine abnormalities accompanying hepatic cirrhosis and hepatoma. J. Clin. Endocr., 17; 1017 (1957).
13.
BarrieJ. I., KlebanoffS. J., CatesG. W.: Direct medullary anterioles and arteriovenous anastomoses in the arcuate soonges of kidney, Lancet, I; 23 (1950).
14.
BencosmeS. A., BergmanB. J.: Ultrastructure of human and experimental glomerular lesions, in: International Review of Experimental Pathology, Academic Press, New York, vol. I, p. 139 (1962).
15.
BerkD. P., EpsteinM., HollenbergN. K.: A continuum of renal circulatory changes associated with the epato-renal syndrome. Gastroenterology.56; 420 (1969).
16.
BerkowitzH. D., MillerL. D., ItskowitzH. D.: Liver disease, renal function and the renin-angiotensin system. Surg. Forum, 19; 391–392 (1968).
17.
BerkowitzH. D., GalvinC., MillerL. D.: Significance of altered renin substrate in the hepatorenal syndrome. Surg. Forum, 23; 342 (1972).
18.
BingJ., MagillF.: Potentiation of sensitization to renin in normal rats by cross circulation with nephrectomized. Acta. Path. Microbiol. Scand., 59; 485 (1963).
19.
BironP., MeyerP., PanissetJ. C.: Removal of angiotensin from the systemic circulation. Can. J. Physiol. Pharmacol., 46; 175–178 (1968).
20.
BironP., HugginsC. G.: Pulmonary activaction of sinthetic angiotensin I. Life Sci., 7; 965–970, (1968).
21.
BlaquierP., HooblerS. W., SchroederJ., GomezA., KreulenT.: Effect of bilateral nephrectomy and pressor response to renin. Amer. J. Physiol, 203; 339 (1962).
22.
BloodworthJ. M. B., SommersS. C.: Cirrhotic glomerulosclerosis, a renal lesion associated with hepatic cirrhosis. Lab. Invest., 8; 962–978 (1959).
23.
BloomW., FawcettD. W.: A Textbook of Histology.W. B. Saunders Company. Philadelphia (1968).
24.
BradleyS. E., BradleyG. P.: The effect increased abdominal pressure on renal function in man. J. Clin. Invest26; 1010–1022 (1947).
25.
BurgenA. S. V., IversenL. L.: Brit. J. Pharmacol., 52; 34–49 (1965).
26.
CalabresiP., AbelmanW. H.: Portacaval and portopulmonary anastomosis in Laennec's cirrhosis and heart failure. J. Clin. Invest., 36; 1757–1265 (1957).
CarreteroO., GrossR.: Renin substrate in plasma under various experimental condition in the rat. Amer. J. Physiol., 213; 695 (1967).
29.
ChalmersT. C.: Pathogenesis and treatment of hepatic failure (Concluded). New Eng. J. Med., 263; 77 (1960).
30.
ChartJ. T., ShipleyE. S.: The mechanism of sodium retention in cirrhosis of the liver, J. Clin. Invest., 32; 560 (1963).
31.
ChiesaA., Ciappig, BaldiL.: Role of various causes of arterial desaturation in liver cirrhosis. Clin. Sci., 37; 803–814 (1969).
32.
CookW. F.: The detection of renin in juxtaglomerular cells. J. Phyol (London), 194; 73–74 (1967).
33.
CombesB., WhalleyP. J., AdamsR. H.: Tetracycline and the liver progress in liver disease [citato da Conn:Gastroenterology, 65; 321 (1973).
34.
ConnH. O.: Ammonia tolerance in liver disease. J. Lab. Clin. Med., 55; 855–871 (1960)
35.
CohnJ. N., TristaniF. E., KhatriI. M.: Renal vasodilator therapy in the hepatorenal syndrome: Med. Ann., 39; I (1970).
36.
CohnJ. N., TristaniF. E., KhatriI. M.: Sistemic vasoconstriction and renal vasodilator effects of PLV-2 (octapressin) in man. Circulation, 38; 151–157 (1964).
37.
CohenR. A., KopinI. J., CrevelingC. R., MusacchioJ. M., FischerJ. E., CroutJ. R., GillJ. R.: False neurochemical transmitter: combined clinical staff conference at the National Institute of Health. Ann. int. Med., 65; 347 (1966).
38.
CondonR. E.: Effect of dietary protein on symptoms and survival in dogs with an Eck fistule. Am. J. Surg., 121; 107 (1971).
39.
ConradM. E., SchwartzF. D., YoungA. A.: Infectious hepatitis. A generalized disease. A study of renal gastrointestinal and hematologic abnormalities. Amer. J. Med., 37; 789 (1964).
40.
CroutJ. R., AlpersH. S., TatumE. L., ShoreP. A.: Release of metaraminol (aramine) from the heart by sympathetic nerve stimulation)Science, 145; 828 (1964).
41.
CrowshawSzylk: Biochem., 116; 421 (1970).
42.
DaviesB. N., HortonE. W., WithringtonP. G.: Occurence of prostaglandin F2 in splenic venous blood of the dog following splenic nerve stimulation. Brit. J. Pharmacol., 32; 127–135 (1968).
43.
DanielsE. G., HinmanI. W.: Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulle. Nature (London), 215; 1298 (1967).
44.
De BonoE., LeeF. R., MottramF. R., PickeringG. W., BrownJ. J., KeenH., PeartS., SandersonP. H.: The action of angiotensin in man. Clin. Sci., 25; 123–157 (1963).
45.
De SanctisA.: Contributo allo studio dell'apparato vascolare dell'ilo renale. Riv. Anat. Pat. Onc., 9; 494–516 (1955).
46.
DodsworthJ. M., JamlesJ. H.: Depletion of brain norepinephrine in acute hepatic coma. Surgery, 75; 811 (1974).
47.
DolleryC. T., GoldbergL. I., PentecostB. L.: Effects of intarrenal infusion od bradykinin and acetylcholine on renal blood flow in man. Clin. Sci., 29; 433 (1965).
48.
DousaT. P.: Effect of prostaglandinis on adenylate cyclase from human renal medulla in « Prostaglandins and Cyclic AMP », ed. by Accademie Press, Inc. pag. 155–156, 1973.
49.
Effects of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Amer. J. Physiol., 209; 659 (1965).
50.
ElkinM., MengC. H.: The effects of angiotensin on renale vascularity in dogs. Amer. J. Roentgen., 98; 927 (1966).
51.
EpsteinM., BerkD. P., HollenbergM. K.: Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am. J. Med., 49; 175–185 (1970).
52.
EpsteinF. H.: Reversible uremic states. J.A.M.A., 161; 494–499 (1956).
FajersC.: Experimental studies in the socalled hepatorenal syndrome. Acta Path. Microbiol. Scand., 44; 5 (1958).
55.
FarquharJ. C.: Renal studies in acute infectious (epidemic) hepatitis. Amer. J. Med. Sci., 218; 291 (1949).
56.
FazekasJ. F., TicktinH. E., EhrmantrautW. R., AlmanA. W.: Amor. J. Med., 21; 843 (1956).
57.
FeldbergW., LewisG. P.: The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin. J. Physiol. (London), 171; 98 (1964).
58.
FerryC. B.: Ann. Rev. Pharmacol., 7; 185–202 (1967).
59.
FichmanLitternberg, HortonWoo.: J. Clin. Investigation, 51; 30 (1972).
60.
FlintA.: Clinical report on hydro-peritoneum, based on an analysis of forty-six cases. Am. J. Med. Sci., 45; 306–339 (1863).
61.
FolinO., DenisW.: The origin and significance of the ammonia in the portal blood. J. Biol. Chem., 11; 161 (1912).
62.
FischerJ. E., HorstW. D., KopinI. J.: B-hydroxylatcd sympathomimetic amines as false neurotrannsmitters. Brit. J. Pharm., 24; 477 (1965).
63.
FischerJ. E.: Neurotransmitters and the hepatorenal syndrome. Conn. Med., 36; 575–581 (1972).
64.
FischerJ. E., JamesI. H.: Treatment of hepatic coma and hepatorenal syndrome. Amer. J. Surg., 123; 222–230 (1972).
65.
FischerJ. E., BaldessariniR. J.: False neurotransmitters and hepatic failure. Lancet, 2; 75–79 (1971).
66.
FischerE. R., HellstromH. R.: The membranous and proliferative glomerulo nephritis of hepatic cirrhosis. Amer., J. Clin. Path., 32; 48 (1959).
67.
FrittsH. W.: Sistemic circulatory adjustments in hepatic disease. Med. Clin. N. Amer., 47; 563 (1963).
68.
GilbertA., LereboulletP.: Des urines retardées (opsiurie) dans les cirrhoses. Comptes Rend. Soc. Biol., 53; 276 (1901).
69.
GillespieJ. S.: Proc. Roy. Soc., Ser. B, 166; 1–10 (1966).
GliedmanM. L., RuzoffR. I., MullaneJ. F., LernerB., FoxL., KarlsonK. E.: The effect of experimental biliary obstruction on the juxtaglomerular apparatus, peripheral plasma aldosterone, and ascites, Amer. J. Surg.111; 138 (1966).
GlowinskiJ., BaldesseriniR. J.: Metabolism of nerepinephrine in the central nervous system. Pharm. Rev., 18; 1201 (1966).
74.
GoldsteinH., BoyleJ. D.: Spontaneaus recovery from the hepatorenal syndrome: report of four cases. N. Engl. J. Med., 272; 895–897 (1965).
75.
GoodwinF. J., KirshmanJ. D., SealeJ. E., LaraghJ. H.: Influence of the pituitary gland on sodium conservation, plasma renin and renin substrate concentrations in the rat. Endocrinology, 86; 824–834 (1970).
76.
GordonR. D., KuchelO., LiddleG. W., IslandD. P.: Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J. Clin. Invest., 46; 599–605 (1967).
77.
GordonM. E.: The acute effects of abdominal paracentesis in Laennec's cirrhosis upon exchanges of electrolytes and water, renal function and hemodynamics. Amer. Gastroenterology, 333; 15–37 (1960).
78.
GornelD. L., LancestremereR. G., PapperS., LowensteinL. M.: Acute changes renal excretion of water and solute in patients with Laennec's cirrhosis induced by the administration of the pressor amine metaraminol J. Clin. Invest., 41; 594 (1962).
79.
GrandchampA., AyerG., TrunigerB.: Pathogenesis of redistribution of intrarenal blood flow in haemorragic hypotension. Europ. Clin. Invest., I; 271–276 (1971).
80.
GouldA. B., SkeggsL. T., KannJ. R.: Measurement of renin substrate concentrations in human serum. Lab. Invest., 15; 1802 (1966).
81.
GrandechampA., TrunigerB., VeyratR.: Intrarenal distribution of blood flow and renin production in hemorrahagic hypotension before and during a-adrenergie blockade. Europ. Soc. Clin. Invest., IV.th Ann. Meeting, Scheveningen 1970.
82.
GumpF. E., MashimaY.: Experimental production of the hepatorenal syndrome and its hemodynamic modification. Europ. surg. Research, 2; 110 (1970).
83.
HaynesF. W., DexterL.: The renal humoral pressor mechanism in man. IV. The hypertensinogen content of the plasma of normal patients with various diseases. J. Clin. Invest., 24; 75 (1945).
HeacoxR., HarveyA. M., VanderA. J.: Hepatic inactivation of renin. Circ. Res., 21; 149 (1967).
87.
HeckerR., SherlockS.: Electrolyte and circulatory changes in terminal liver failure. Lancet, 2; 1121–1125 (1956).
88.
HicklerR., LaulerD., SaravisC., VagnucciA., SteinerG., ThornG.: Vasodepressor lipid from the renal medulla. Canad. med. Ass. J., 90; 280 (1964).
89.
HedquistP.: Modulating effect of proctaglandin E2 on noradrenalin release from isolated cat spleen. Acta Physiol. Scand., 75; 511–512 (1969).
90.
HelwingF. C., SchutzC. B.: A liver kidney syndrome. Clinical pathological and experimental studies. Surg., Gynecol. & Obst., 55; 570 (1932).
91.
HeydC. G.: Hepatitis associated with or sequential to infiamatory diseases of the abdomen. Long Island M. J., 17; 17 (1923).
92.
HodgeR. L., VaneJ. R.: Disappearance of angiotensin from the circulation of the dog. Nature (London), 215; 138–141 (1967).
93.
HollenbergN. K.: The role of the sympathetic nervous system in the development of decompensation during hemorrhagic shock. Ph. D. Thesis. University of Manitoba. National Library, Public. Archives, Ottawa, Canada1965.
94.
HollenbergN. K., EpsteinM., RosenS. M., BaschR. I., OkenD. E., MerrilJ. P.: Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine, 47; 455 (1968).
95.
HoussayB. A., DexterL.: The sensitivity to hypertensin, adrenalin and renin of unanaesthetized normal, adrenalectomized, hypophysectomized and nephrectomized dogs. Ann. intern. Med., 17; 451–460 (1942).
96.
IberF. L., RosenH., LevensonS. M., ChalmersT. C.: The plasma amino acids in patients with liver failure. J. Clin. Lab. Med.50; 417 (1957).
97.
ItskovitzH. D., TerragnoN. A., McGiffJ. C.: Effect of a renal Prostaglandine on distribution of blood flow in the isolated canine kidney. Circ. Res., 34; 770–776 (1974).
98.
IversenL. L.: J. Pharm. Pharmacol., 17; 62–64 (1965).
99.
IwatsvkiS., PopovtzerM., CormanJ., StarzlT.: Recovery from hepatorcnalsyndrome after orthotopic liver transplantation. N. Engl. J. Med., 289; 1155–1159 (973).
100.
JickH., KammD. E., SnyderJ. G.: On the concentrating defect in cirrhosis of the liver. J. Clin. Invest., 43; 258–266 (1964).
101.
JonesC. M., EatonF. B.: The prognostic significance of spontaneus diuresis in acute or subacute disease of the liver. New Engl. J. Med., 213; 907 (1935).
102.
JonesW. A., RaoD. R. G., BraunsteinH.: The renal glomerulus in cirrhosis of the liver. Amer. J. Path., 39; 393 (1961).
KakimotoArmstrong: J. Biol. Chem., 237; 422 (1962).
105.
KewM. C., BruntP. W., VarmaR. R.: Renal and intrarenal blood-flow in cirrhosis of the liver, Lancet, 2; 504–509 (1971).
106.
KeithCrowshaw: Nature new biology.231; 25 (1971).
107.
KhairallahP. A., BumpusE. M., PageI. H., SmebyR. R.: Angiotensinase with a high degree of specificity in plasma and red cells. Science, 140; 672–674 (1963).
108.
KlingerE. L., VaamondeC. A.Jr., VaamondeL. S., LancestremereR. G., MorosiH. I., FrischE., PapperS.: Renal function changes in cirrhosis of the liver: A prospective study. Arch, intern. Med., 125; 1010 (1970).
109.
KnauerC. M., LoveH. M.: Hemodynamics in the cirrhotic patient during paracentesis. N. Engl. J. Med., 276; 491–496 (1967).
KopinI. J., FischerJ. E., MusacchioJ. M., HorstW. D., WeiseV. K.: False neurochemical transmitters and the mechanism of sympathetic blockade by monoamine oxidase inhibitors. J. Pharmacol. Exp. Ther., 147; 186–193 (1965).
112.
KopinI. J., FischerJ. E., MusacchioJ. M., HorstW. D.: Evidence for a false neuro-chemical transmitters as a mechanism for the hypotensive effect of monoamine oxidase inhibitors. Proc. Nat. Sci., 52; 716–721 (1964).
113.
KopinI. J., FischerJ. E., MusacchioJ.Hors2W. D., WeiseV. K.: Proc. Nat. Sci., 147; 186 (1965).
114.
FischerJ. E., HorstW. D., KopinI. J.: Brit. J. Pharmacol., 24; 477 (1965).
115.
KoppelM. H., CoburnJ. W., MimsM. M.: Transplantation of cadaveric kidney from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N. Engl. J. Med., 280; 1367–1371 (1969).
116.
KörnerP. I., StokesG. S., WhiteS. W., CalmersJ. P.: Role of the automatic nervous system in the renal vasoconstriction response to hemorrhage in the rabbit. Circulat. Res., 20; 676 (1967).
117.
KowalskiH. J., AbelmannW. H., McNeeleyW. F.: The cardiac output in patients with cirrhosis of the liver and tense ascites, with observation on the effect of paracentesis. J. Clin. Invest., 33; 768–773 (1954).
118.
KurtmanN. A., HullA. R., Martinez-MaldonadoM., RectorF. C.Jr., SeldinD. W.: Significance of natriuretic hormone in edematous states. Amer. Soc Nephrol. Abstracts, 36 (1967).
119.
LarssonC., AnggardE.: Regional difference& in the formation and metabolism of PG in the rabbit KidneyEur. J. Pharm., 21; 30 (1973).
120.
LeeJ. B.: Advances in the bioscences international conferences on prostaglandins. Pergamon Press, Vieweg, 19; 277 (1972).
121.
LeeJ. B., HicklerR. B., SaravisC. A., ThornG. D.: Sustained depressor effect of renal medullary extract in normotensive rat. Circ. Res., 13; 359 (1963.
LeloirL. F., MunozJ. M., TaquiniA. C., Braun-MenendezE., FascioloJ. C.: La formacion del hipertensionogen. Rev. Arg. Cardiol., 9; 269–277 (1942).
124.
LeslieS. H., JohnstonB., RalliE.: Renal function as a factor in fluid retention in patients with cirrhosis of the liver. J. Clin. Invest.30; 1200–1220 (1951).
125.
LevineR. J., ConnH. O.: Tyrosine metabolism in patients with liver disease. J. Clin. Invest., 46; 2012 (1967).
126.
LewisH. A., GoldblattH.: Studies on experimental hypertension. Bull. N. Y. Acad. Med., 18; 459–470 (1942).
127.
LiebermanF. L., ReynoldsT. B.: Renal failure with cirrhosis. Observations on the role of diuretics Ann. int. Med., 64; 6 (1966).
128.
LiebermanF. L.: Functional renal failure in cirrhosisGastroenterology, 58; 108 (1970).
129.
LjungqvistA.: The intrarenal arterial pattern in the normal and diseased human kidney. A. micro-angiographihe and histologic study. Acta Med. Scand., 174, Supp. 401, 1 (1963).
130.
LonigroA. J., ItskovitzH. D., CrowshawK., McGiffJ. C.: Dependency of renal blood flow on prostaglandin Synthesis in the dog. Circ. Res., 32; 712–717 (1973).
131.
MattsonW. J.Jr., LobV., SloanM., CoonW. W., TurcotteJ. G., ChildG. G.: Alteration of individual free amino acids in brain during acute hepatic coma. Surg., Gynec. & Obst., 130; 263 (1970).
132.
LobV., MattsonW. J.Jr., SloanM., CoonW. W., TurcotteJ. G., ChildC. G.: Alterations in plasma free amino acids in dogs with hepatic insufficiency. Surg., Gynec. & Obst., 130; 794 (1970).
133.
MashfordM. L., MahonW. A., ChalmersT. C.: Studies of the cardiovascular system in the hypotension of liver failure. N. Engl. J. Med., 267; 1071–1074 (1962).
134.
McDonaldF. D., BrennanL. A., TurcotteJ. G.: Severe hypertension and elevated plasma renin activity following tranplantation of « hepato-renal donor » kidneys into anephric recipients, A. M. J. Med., 54; 39–43 (1973).
135.
McGiffJ. C., TerragnoN. A., StrandJ. C., LeeJ. B.: Selective passage of prostoglandins across the lung. Nature, 223; 742–745 (1969).
136.
MerrilA., WilliamsJ. R., HarrisonJ. R.: The site of action of the renal pressor substance. Amer., J. Med. Sci., 196; 18 (1938).
137.
MichelakisA. M., CaudleJ., LiddleG. W.: In vitro stimulation of renin production by epinephrine, norepinephrine and cyclic AMP (33647). Proc. Soc. Exp. Biol. (N. Y.), 130; 748 (1969).
138.
SpellbergM. A.: Diseases of the liver. Grune & Stratton, 479, 487, New York 1954.
139.
MolinoffP. B., LandsbergL., AxelrodJ.: An enzymatic assay for octopamine and other B-hydroxylated phenylethylamines. J. Pharm. exp. Ther., 170; 253 (1969).
140.
MolinoffP. B., AxebrodJ.: Octopamine: normal occurance in sympatetic nerves of rats. Science, 164; 428–429 (1969).
141.
MontgueD.: Kinetics of renin-angiotensin reaction in plasma of normal and nephrectomized rats. Amer. J. Physiol., 215; 78 (1968).
MuirheadJonesStirmnang Antihypertensive property in renoprival hypertension of extract from renal medulle, 56; 167 (1970).
144.
MusacchioJ., KopinI. J., WeissV. K.: Subcellular distribution of some sympathomimetic amines and their B-hydroxylated derivates in rat heart. J. Pharm. Exp. Ther., 148; 22 (1965).
MullaneJ. F., GliedmanM. L.: Elevation of the pressure in the abdominal inferior vena cava as a cause of a hepatorenal syndrome in cirrhosis. Surgery, 59; 1135–1146 (1966).
147.
MullaneJ. F., GliedmanM. L.: Development of renal impairment in Laennec's cirrhosis. Ann. Surg., 174; 892–901 (1971).
148.
Noorden (von)C.: Metabolism and Pratical Medicine. Vol. 2, Pathology, W. T. Keener, 207, Chicago, 1907.
149.
PapperS.: The kidney in liver disease, Disease of the kidney.StraussM. B., WeltL. G., Little Brown & Co., p. 841, Boston, 1963.
150.
PapperS., BelskyJ. L., BleiferK. H.: Renal failure in Laennec's cirrhosis of the liver: I. description of clinical and laboratory features. Ann. Inter. Med., 51; 759 (1959).
151.
PapperS., RosenbaumJ. D.: Abnormalities in the excretion of water and sodium in compensated cirrhosis of the liver. J. Lab. Clin. Med., 40; 523–530 (1952).
152.
PapperS.Vaamonde: The kidney in liver disease. Diseases of the kidney.StaussM. B., WeltL. G., Little Brown & Co., 1139–1154, Boston, 1971.
153.
PapperS., SaxsonL.: The diuretic response to administered water in patients with liver disease. Arch, intern. Med., 103; 750–757 (1959).
154.
PapperS., SeiferH. W., SaxsonL.: The diuretic response to administered water in patients with liver disease: I. Acute infectious hepatitis. A.M.A. Arch, intern. Med., 103; 746 (1959).
155.
PapperS., VaamondeV. A.: Renal failure in cirrhosis role of splasma volume. Ann. intern. Med., 68; 958 (1968).
156.
ParkesJ. D., SharpstoneP., WilliamsR.: L-dopa in hepatic coma. Lancet, 2; 1341 (1970).
157.
PetersonO., TygstrupN., WalkerK.: Roentgen examination or the inferior vena cava in chronic hepatic disease. Acta Radiol., 55; 97 (1961).
158.
PhillipsG. B., SchwartzR., GabuzdaG., DavidsonC. S.: The syndrome of impeding hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. New Engl. J. Med., 247; 239 (1952).
159.
PickensP. T., BumpusF. M., LloydA. M., SmebyR. R., PageI. H.: Measurement of renin activity in human plasma. Circ. Res., 17; 438 (1965).
160.
Pollockg Preicteric stage infective hepatitis, vale of biochemical findings in diagnosis. Lancet, 2; 626 (1945).
161.
PomeranzB. H., BirtchA. G., BargerA. C.: Neural control of intrarenal blood flow. Amer. J. Physiol., 215; 1067 (1968).
162.
PopperH., SchaffnerF.: Liver structure and function.Blakiston, McGraw Hill Book Co. Inc. p. 648, 1957.
163.
RannigerK., SwitzD.: Local obstruction of inferior vena cava by massive ascites. Am. J. Roentgenol., 93; 935–939 (1965).
164.
RatnoffO. D., PatekA. J.Jr.: The natural history of Laennec's cirrhosis of the liver: an analysis of 386 cases. Medicine, 21; 207–268 (1942).
165.
ReevesG., LowensteinL. M., SommerS. C.: The macula densa and the juxtaglomerular body in cirrhosis. Arch. intern. Med., 112; 708 (1963).
166.
RosenS. M., GrandchampA., StrebelH., KriekH. R.: Redistribution of renal blood flow in hemorragic hypotension: Role of renal nerves and circulating catecholamines. Europ. J. Clin. Invest., 1; 277–280 (1971).
167.
RosenS. M., TrunigerB., KriekH. R., MurrayJ. E., MerrilJ. P.: Intrarenal distribution of blood flow in the transplanted dog kidney: effect denervation end rejection. J. Clin. Invest.46; 1239 (1967).
168.
RosenS. M., HollnebergN. K., DealyJ. B.Jr., MerrilJ. P.: Measurement of distribution of blood flow in the human kidney using the intra-arterial injection of xe. Relationship to function in the normal and tranplanted kidney. Clin. Sci., 34; 287 (1968).
169.
RubiniM. R.: Colloquium on hepatorenal syndrome. Albuquerque N. M., September 24 (1966).
170.
RubinsonR. M., VaskoJ. S., DoppmanJ. L.: Intra-abdominal pressure and vena cava obstruction. Arch. Surg., 94; 766 (1967).
SaidS. I., MuttV.: Polypeptide with broad biological activity: isolation from small intestine. Science, 169; 1217–1218 (1970).
173.
SalomonM. L., SakaguchiH., ChurgJ., DachsS., GrishmanE., MautnerW., ParonettF., RosenthalW. S.: Renal lesions in hepatic disease. A study based on kidney biopsies. Arch. Intern. Med., 115; 704 (1965).
174.
SchalesO.: Amino acid decarboxulases p. 216; The Enzymes vol. 2, part. I, SummersJ. B., & MyrbackK., Ed. Academic Press, New York, 1951.
175.
ShaldonS., WalkerG.: Jaundice and acute renal failure Aktuelle Probleme der Hepatologie: Ultrastruktur, stevoidstoff-Wechsel, Surchblutung Leber Niere.MartiniG. A., SherlockS., Georg Thieme Verlag, p. 118, Stuttgart, 1962
176.
SchedlH. P., BarterF. C.: An explanation and experimental correction of the abnormal water diuresis cirrhosisJ. Clin., Invest., 39; 248 (1960).
177.
SnellA. M.: Effects of cronic disease of the liver on composition and psysiochemical properties of blood: change in the serum proteins; reduction in the oxygen saturation of arterial blood. Ann. Intern. Med.9; 690–711 (1935).
178.
ShearL., HallP. W., GabuzdaG. J.: Renal failure in patients with cirrhosis of the liver: II. Factors influencing maximal urinary flow rate. Amer. J. Med., 39; 199–209 (1965).
179.
ShearL., KleinermanJ., GabuzdaG. J.: Renal failure in patients with cirrhosis of the liver: I. Clinical and pathological characteristics. Amer. J. Med., 39; 184–198 (1965).
180.
SchroederE. T., Shear, SancettoS. M.: Renal failure in patients with cirrhosis of the liver: III. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin. Amer. J. Med., 43; 887–896 (1967).
181.
SchroederE. T., NumannP. J., ChamberlainB. E.: Functional renal failure m cirrhosis. Recovery after portacaval shunt. Ann. intern. Med., 72; 923–928 (1970).
182.
SchroederE. T., EichR. H., SmulyanH., GouldA. B., GabuzdaG. J.: Plasma renin levels in hepatic cirrhosis: relation to functional renal failure. Amer. J. Med., 49; 186 (1970).
183.
ScroopG. C., LoweR. D.: Central pressor effect of angiotensin mediated by the parasympathetic nervous system. Nature, 220; 1331–1332 (1968).
184.
ScroopG. C., WhelanR. F.: A central vasomotor action of angiotensin in man. Clin. Sci., 30; 79–90 (1966).
185.
SelkurtE. E., HallP. W., SpencerM. P.: Response of renal blood flow and clearance to graded partial obstruction of the renal vein Amer. J. Physiol., 157; 40 (1949).
ShorrE., ZweifachB. W., FurchottR. F.: Hepatorenal factors in circulatory hemostsis. Influence of humoral factors of hepatorenal origin on vascular reaction to hemorrage. Ann. N. Y. Acad Sci., 49; 571 (1948).
188.
ShorrE.: Hepatorenal vasotropic factors in experimental cirrhosis. In HoffbauerF. W.; Liver Injury. Transaction of the sixth Conference, Josiah Macy jr. Foundation, New York, 1947.
189.
StolarczykJ., CaroneF. A.: Micropuncture study of the effect of lymphatic occlusion and partial renal vein occlusion on renal function. Fed. Proc. Part. 1, 24; 435 (1965).
190.
StrongC. G., BohrD. F.: Effect of several prostaglandins on isolated vascular smooth muscle. Prostaglandin Symposium of the Worcester Fondation (Eds. RamwellP. W., and ShawJ. E.) p. 225–239. Interscience, New York1968.
191.
SugermanH. J., BerkwitzH. D., DavidsonD. T., MillerL. D.: Treatment of the hepatoral syndrome with metaraminol. ‘Surg. Forum, 21; 359 (1970).
192.
SummerskillW. H. J.: Hepatic failure and the kidney. Gastroenterology, 51; 941 (1966).
193.
SummerskillW. H. J., ShorterR. G.: Progressive hepatic failure. Its association with undifferentiated renal tumor. Arch. Intern. Med., 120; 81–94 (1967).
194.
The prostaglandins: Pharmacological and therapeutic advances, Ed. Cuthbert M. B., London1973.
195.
ThorburnG. D., KopaldH. H., HerdJ. A., HollenbergM., O'MorchoeW. C., BargerA. C.: Intrarenal distribution of nutrient blood flow determined with krypton in the unnanesthetized dog. Circ. Res., 13; 290 (1963).
196.
TobianL., VietsJ.: Potentiation of in vitro norepinephrine vasocontriction with prostaglandin E. I. Fed. Proc, 29; a87 (1970).
197.
ThoringtonJ. M., SchidtC. F.: A study urinary output and blood pressure changes resulting in experimental ascites. Amer. J. Med. Sci., 165; 880–890 (1923).
198.
TrendelenburgU., MuskusA., FlemingW. W., Alonso de la SierraE. G.: J. Pharm. Exper. Ther., 138; 181–193 (1962).
199.
TristaniF. F., CohnJ. N.: Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion. J. Clin. Invest., 46; 1894–1906 (1967).
200.
VaamondeC. A., VaamondeL. S., MorosiH. J., KlingleE. L.Jr., PapperS.: Renal concentrating ability in cirrhosis: II. Role of vasopressin and urea, and comparison with diluting ability (Submited for pubblication).
201.
VaamondeC. A., VaamondeL. A., PresserJ. L., MorpiH. J., KlingerE. L.Jr., PapperS.: The role of vasopressin and urea in the renal concentrating defect of patients with cirrhosis of the liver. Clin. Sci., 41; 441 (1971).
202.
VanderA. J.: Control of renin release. Physiol. Rev., 47; 359 (1967).
203.
VargishT., LevinR., CottonJ.: Changes in renal function and intrarenal blood flow distribution due to a humoral factor produced by hepatic ischemia. Ann. Surg, (in press).
WartmanW. B., RusterholzA. P., TuckerJ. M.: Effect of renal ischemia on production of experimental nephrosis in jaundiced rabbits. Amer. J. Path., 26; 235 (1950).
206.
WerleE., VogelE., GoldelF. L.: Ueber ein biutdrucksteigerndes Prinzip in Extrakten aus der Glandula submaxillaris der weissen Maus. Arch. Exper. Pathol. Pharmakol., 230; 236–244 (1957).
207.
WennekerA. S., FischerG. L.: Immediate changes in blood volume following paracentesis. Clin. Res. Proc, 5; 216 (1957).
208.
WickhamJ. E. A., SharmaG. P.: Endogenous ammonia formation in experimental renal ischemia. Lancet, 1; 195–199 (1965).
209.
WinerN., ChokshiD. S., YoonM. S., FreedmanA. D.: Adrenergic receptor mediation of renin secretion. J. Clin. Endocrinol., 29; 1168–1175 (1969).
210.
ZimmermanB. G., WhitmoreL.: Effect of angiotensin and phenoxybenzamine on release of norepinephrine in vessels during sympathetic nerve stimulation. Neuropharmacol., 6; 27–38 (1967).
211.
ZimmermanG. B., GomezJ.: Increased response to sympathetic stimulation in the cutaneous vasculature in presence of angiotensin. Int. J. Neuropharmacol., 4; 185–193 (1965).
212.
ZusmanCaldwellSperoff: A possible control mechanism for the synthesis and release of prostaglandin A from the kidney. J. Clin. Invest., pp. 153.
213.
KlatskinKrehl: The effect of alcohol on the choline requirement. Incidence of renal necrosis in weanling rats following short term ingestion of alcohol. J. Exp. Med., 100; 615 (1954).